- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of New Technologies in Myeloproliferative Neoplasms
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-26
DOI
10.3389/fonc.2019.00321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients
- (2018) Francesca Palandri et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pyrosequencing-based quantitative measurement of CALR mutation allele burdens and their clinical implications in patients with myeloproliferative neoplasms
- (2018) Yejin Oh et al. CLINICA CHIMICA ACTA
- MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis
- (2018) Paola Guglielmelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management
- (2018) Ayalew Tefferi AMERICAN JOURNAL OF HEMATOLOGY
- A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
- (2018) Dorota Link-Lenczowska et al. ANNALS OF HEMATOLOGY
- Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls
- (2018) Nabih Maslah et al. ANNALS OF HEMATOLOGY
- Skewed ratio between type 1 and type 2 calreticulin mutations in essential thrombocytosis patients with concomitant Janus kinase 2 V617F mutation
- (2018) Laura M. Haunstrup et al. EXPERIMENTAL HEMATOLOGY
- Classification and Personalized Prognosis in Myeloproliferative Neoplasms
- (2018) Jacob Grinfeld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
- (2018) Ulrike Bacher et al. Blood Cancer Journal
- Comparison of JAK2 V617F -positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology
- (2017) Roberto Latagliata et al. HEMATOLOGICAL ONCOLOGY
- Detection of CALR and MPL Mutations in Low Allelic Burden JAK2 V617F Essential Thrombocythemia
- (2017) Fabrice Usseglio et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis
- (2017) A Tefferi et al. LEUKEMIA
- A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
- (2017) F Passamonti et al. LEUKEMIA
- Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology
- (2017) Paola Guglielmelli et al. LEUKEMIA RESEARCH
- Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms
- (2017) Yu-Cheng Chang et al. MEDICAL ONCOLOGY
- Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories
- (2017) Margherita Perricone et al. Oncotarget
- Detection ofCALRMutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing
- (2016) Juli-Anne Gardner et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Laboratory Investigation of Myeloproliferative Neoplasms (MPNs)
- (2016) Lambert Busque et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo clinic patients
- (2016) Mahnur Haider et al. AMERICAN JOURNAL OF HEMATOLOGY
- Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR
- (2016) Miguel Waterhouse et al. ANNALS OF HEMATOLOGY
- Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
- (2016) M. Araki et al. BLOOD
- Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
- (2016) William Vainchenker et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Myeloproliferative neoplasms: Current molecular biology and genetics
- (2016) Kolsoum Saeidi CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms
- (2016) Francesco Passamonti et al. CURRENT OPINION IN HEMATOLOGY
- An accurate, simple prognostic model consisting of age, JAK2 , CALR , and MPL mutation status for patients with primary myelofibrosis
- (2016) Uri Rozovski et al. HAEMATOLOGICA
- Validation of a molecular diagnostic assay forCALRexon 9 indels in myeloproliferative neoplasms: identification of coexistingJAK2andCALRmutations and a novel 9 bp deletion inCALR
- (2016) G. Murugesan et al. International Journal of Laboratory Hematology
- Quantification of the Mutant CALR Allelic Burden by Digital PCR
- (2016) Olivier Mansier et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2016) Ruben Mesa et al. Journal of the National Comprehensive Cancer Network
- JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens
- (2016) Olivier Mansier et al. LEUKEMIA & LYMPHOMA
- Next-generation sequencing: advances and applications in cancer diagnosis
- (2016) Simona Serratì et al. OncoTargets and Therapy
- Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
- (2016) S. Elf et al. Cancer Discovery
- Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms
- (2016) Stephan Bartels et al. Oncotarget
- An accurate, simple prognostic model consisting of age, JAK2 , CALR , and MPL mutation status for patients with primary myelofibrosis
- (2016) Uri Rozovski et al. HAEMATOLOGICA
- Development and Validation ofCALRMutation Testing for Clinical Diagnosis
- (2015) Cheryl L. Maier et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Clinical Validation of a Multipurpose Assay for Detection and Genotyping ofCALRMutations in Myeloproliferative Neoplasms
- (2015) Meenakshi Mehrotra et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib
- (2015) K. P. Patel et al. BLOOD
- Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
- (2015) I. Chachoua et al. BLOOD
- Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis
- (2015) C. Marty et al. BLOOD
- Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
- (2015) X. Cabagnols et al. BLOOD
- Real-Time PCR and Droplet Digital PCR: two techniques for detection of theJAK2V617Fmutation in Philadelphia-negative chronic myeloproliferative neoplasms
- (2015) G. Fontanelli et al. International Journal of Laboratory Hematology
- Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
- (2015) D Pietra et al. LEUKEMIA
- Increased frequency of co-existingJAK2exon-12 orMPLexon-10 mutations in patients with lowJAK2V617Fallelic burden
- (2015) Roberto H. Nussenzveig et al. LEUKEMIA & LYMPHOMA
- Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms
- (2015) Amy V. Jones et al. LEUKEMIA RESEARCH
- Myeloproliferative Neoplasms
- (2015) Ayalew Tefferi et al. JAMA Oncology
- The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
- (2014) A. Tefferi et al. BLOOD
- Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study
- (2014) P. Guglielmelli et al. BLOOD
- Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
- (2014) R. Rampal et al. BLOOD
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
- (2014) A Tefferi et al. LEUKEMIA
- CALR mutations and a new diagnostic algorithm for MPN
- (2014) Ayalew Tefferi et al. Nature Reviews Clinical Oncology
- Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon -2a
- (2013) A. Quintas-Cardama et al. BLOOD
- A Multiplexed Fragment Analysis-Based Assay for Detection of JAK2 Exon 12 Mutations
- (2013) Larissa V. Furtado et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Detection of MPL Mutations by a Novel Allele-Specific PCR-Based Strategy
- (2013) Larissa V. Furtado et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
- (2013) M Ladetto et al. LEUKEMIA
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
- (2013) J V Jovanovic et al. LEUKEMIA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis
- (2012) T. Barbui et al. BLOOD
- JAK2V617F allele burden is associated with transformation to myelofibrosis
- (2012) Maya Koren-Michowitz et al. LEUKEMIA & LYMPHOMA
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms
- (2011) D. Pietra et al. HAEMATOLOGICA
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Nested High-Resolution Melting Curve Analysis
- (2011) Serge Carillo et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
- (2011) John Mascarenhas et al. Clinical Epigenetics
- Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms
- (2011) N. C. P. Cross Hematology-American Society of Hematology Education Program
- Clinical utility of routineMPLexon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis
- (2010) Elaine M. Boyd et al. BRITISH JOURNAL OF HAEMATOLOGY
- LNK mutation studies in blast-phase myeloproliferative neoplasms and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
- (2010) A Pardanani et al. LEUKEMIA
- A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications
- (2010) F Passamonti et al. LEUKEMIA
- From Palliation to Targeted Therapy in Myelofibrosis
- (2010) Alessandro M. Vannucchi NEW ENGLAND JOURNAL OF MEDICINE
- Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele
- (2009) P. Guglielmelli et al. BLOOD
- Sensitive detection of MPLW515L/K mutations by amplification refractory mutation system (ARMS)-PCR
- (2009) Jian Zhuge et al. CLINICA CHIMICA ACTA
- Calreticulin: non-endoplasmic reticulum functions in physiology and disease
- (2009) Leslie I. Gold et al. FASEB JOURNAL
- Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory
- (2009) Jason D. Merker et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Concordance of assays designed for the quantification of JAK2V617F: a multicenter study
- (2008) E. Lippert et al. HAEMATOLOGICA
- Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis
- (2008) S. Schnittger et al. HAEMATOLOGICA
- Rapid real-time PCR assay for detection ofMPL W515Lmutation in patients with chronic myeloproliferative disorders
- (2008) M. GHADERI et al. International Journal of Laboratory Hematology
- A Sensitive Detection Method for MPLW515L or MPLW515K Mutation in Chronic Myeloproliferative Disorders with Locked Nucleic Acid-Modified Probes and Real-Time Polymerase Chain Reaction
- (2008) Alessandro Pancrazzi et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
- JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies
- (2008) William Vainchenker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now